The rising demand for GLP-1 medications has created an unexpected market for cadaver fat grafting procedures. As weight-loss drugs dramatically reduce body fat, some individuals seek fat transfer solutions from deceased donors to restore facial volume and aesthetic contours. This emerging practice raises significant ethical and medical considerations about consent, safety, and the commodification of human tissue in modern medicine.

Summary auto-generated by AI from the original publisher's content. Editorial standards.